An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy

CNS Drugs

Volumn 22, Issue 5, 2008, Pages 417-442

  Zin, Che S ^a   Nissen, Lisa M ^a   Smith, Maree T ^a   O'Callaghan, James P ^b   Moore, Brendan J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Antidepressants, therapeutic use; Antiepileptic drugs, therapeutic use; Diabetic nephropathies, treatment; GABA receptor agonists, therapeutic use; Local anaesthetics, therapeutic use; Neuropathic pain, treatment; NMDA receptor antagonists, therapeutic use

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; DESIPRAMINE; DEXTROMETHORPHAN; DULOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; LORAZEPAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; OPIATE DERIVATIVE; OXCARBAZEPINE; OXYCODONE; PHENYTOIN; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATAXIA; BLURRED VISION; BURN; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DRESS SYNDROME; DROWSINESS; DRUG EFFICACY; DRUG RESEARCH; DYSPEPSIA; ERYTHEMA; FATIGUE; HEADACHE; HUMAN; HYPERGLYCEMIA; INSOMNIA; LIVER FUNCTION TEST; MOTOR DYSFUNCTION; MULTIPLE ORGAN FAILURE; NAUSEA; NEUROPATHIC PAIN; OPIATE ADDICTION; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN REDNESS; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SWEATING; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; VISUAL DISORDER; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

EID: 41949119381     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200822050-00005     Document Type: Review

References (171)

1. Merskey H, Bogduk N. Classification of chronic pain. 2nd ed. Seattle: IASP Press, 1994
2. Nicholson B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000; 101 (6): 359-71
3. Smith TE, Chong MS. Neuropathic pain. Hosp Med 2000; 61 (11): 760-6
4. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 2002; 18 (6): 343-9
5. Harden RN. Chronic neuropathic pain: mechanisms, diagnosis, and treatment. Neurologist 2005; 11 (2): 111-22
6. Jensen TS, Gottrup H, Sindrup SH, et al. The clinical picture of neuropathic pain. Eur J Pharmacol 2001; 429 (1-3): 1-11
7. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18 (6): 350-4
8. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118 (3): 289-305
9. Hempenstall K, Nurmikko TJ, Johnson RW, et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. J Public Med 2005; 2 (7): 628-44
10. Johnson RW. Herpes zoster: predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 2001; 47: 1-8
11. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67 (2-3): 241-51
12. Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63 (6): 959-65
13. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999; 3 (4): 335-42
14. Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986; 20 (6): 651-64
15. Dworkin RH, Portenoy RK. Proposed classification of herpes-zoster pain. Lancet 1994; 343 (8913): 1648
16. Demoragas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol 1957; 75 (2): 193-4
17. Watson CPN, Evans RJ, Watt VR, et al. Post-herpetic neuralgia: 208 cases. Pain 1988; 35 (3): 289-97
18. Sinnreich M, Taylor BV, Dyck PJB. Diabetic neuropathies: classification, clinical features, and pathophysiological basis. Neurologist 2005; 11 (2): 63-79
19. Gooch C, Podwall D. The diabetic neuropathies. Neurologist 2004; 10 (6): 311-22
20. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. J Diabetes Complications 1992; 6 (1): 49-57
21. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort; the Rochester Diabetic Neuropathy Study. Neurology 1993; 43 (4): 817-24
22. Manes C, Papazoglou N, Sossidou E, et al. Prevalence of diabetic neuropathy and foot ulceration: identification of potential risk factors: a population-based study. Wounds 2002; 14 (1): 11-5
23. Boulton AJM, Knight G, Drury J, et al. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985; 8 (2): 125-8
24. Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am 1996; 25 (2): 325-59
25. Namaka M, Gramlich CR, Ruhlen D, et al. A treatment algorithm for neuropathic pain. Clin Ther 2004; 26 (7): 951-79
26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1-12
27. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-3
28. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47 (3): 305-12
29. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32
30. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992; 48: 29-36
31. Watson CPN, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51 (4): 1166-71
32. Radford G, Steven B, Shaw LR, et al. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000; 16 (3): 188-92
33. Kvinesdal B, Molin J, Froland A, et al. Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251 (13): 1727-30
34. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depresses mood. Neurology 1987; 37: 589-96
35. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991; 45 (1): 3-9
36. Rowbotham MC, Goli V, Kunz NR, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004; 110 (3): 697-706
37. Goldstein DJ, Lu YL, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116 (1-2): 109-18
38. Raskin J, Pritchett YL, Wang FJ, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6 (5): 346-56
39. Wernicke JF, Pritchett YL, D'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67 (8): 1411-20
40. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Trials Ther 1992; 52: 547-52
41. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326 (19): 1250-6
42. Sindrup SH, Gram L, Skjold T, et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. a double-blind cross over study. Br J Clin Pharmacol 1990; 30: 683-91
43. Vrethem M, Boivie J, Arnqvist H, et al. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997; 13 (4): 313-23
44. Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003; 60 (8): 1284-9
45. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42 (2): 135-44
46. Gomez-Perez FJ, Rull JA, Dies H, et al. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study. Pain 1985; 23 (4): 395-400
47. Mico JA, Ardid D, Berrocoso E, et al. Antidepressants and pain. Trends Pharmacol Sci 2006; 27 (7): 348-54
48. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001; 26 (1): 21-9
49. + exchange in rat-brain cortex synaptosomes. Can J Physiol Pharmacol 1990; 68 (11): 1414-8
50. McNair DM, Lorr M, Droppleman LF. Profile of mood states (POMS) manual. San Diego (CA): Educational and Industrial Testing Service, 1992
51. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62
52. Khawam EA, Laurencic G, Malone DA. Side effects of antidepressants: an overview. Cleve Clin J Med 2006; 73 (4): 351-61
53. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279 (4): 287-91
54. Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75 (3): 234-41
55. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medication: association with use of tricyclic agents. Am J Med 2000; 108: 2-8
56. Liu B, Anderson G, Mittmann N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351 (9112): 1303-7
57. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain; diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60 (11): 1524-34
58. Ritch R, Krupin T, Henry C, et al. Oral imipramine and acute angle-closure glaucoma. Arch Ophthalmol 1994; 112 (1): 67-8
59. Khalifa M, Daleau P, Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999; 291 (1): 280-4
60. Chong MS, Hester J. Diabetic painful neuropathy. Drugs 2007; 67 (4): 569-85
61. Coluzzi F, Mattia C. Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des 2005; 11: 2945-60
62. Spinks D, Spinks G. Serotonin reuptake inhibition: an update on current research strategies. Curr Med Chem 2002; 9 (8): 799-810
63. Collins SL, Moore RA, McQuay HJ, et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000; 20 (6): 449-58
64. Sindrup SH, Otto M, Finnerup NB, et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005; 96: 399-409
65. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-27
66. Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM 2005; 98 (1): 29-34
67. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280 (21): 1837-42
68. Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo controlled study. Pain 2001; 94 (2): 215-24
69. Dworkin RH, Corbin AE, Young JP, et al. Pregabalin for the treatment of postherpetic neuralgia; a randomized, placebo-controlled trial. Neurology 2003; 60 (8): 1274-83
70. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004; 109 (1-2): 26-35
71. Chandra K, Shafiq N, Pandhi P, et al. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial. The GONIP Trial. Int J Clin Pharmacol Ther 2006; 44 (8): 358-63
72. Rull JA, Quibrera R, Gonzalez H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double-blind crossover trial. Diabetologia 1969; 5 (4): 215-8
73. Wilton TD. Tegretol in treatment of diabetic neuropathy. S Afr Med J 1974; 48 (20): 869-72
74. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977; 22 (2): 196-9
75. Chadda V, Mathur M. Double-blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26: 403-6
76. Kochar DK, Jain N, Agarwal RP, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes: a randomized placebo controlled study. Acta Neurol Scand 2002; 106 (5): 248-52
77. Kochar DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004; 97 (1): 33-8
78. Otto M, Bach FW, Jensen TS, et al. Valproic acid has no effect non-pain in polyneuropathy; a randomized, controlled trial. Neurology 2004; 62 (2): 285-8
79. Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005; 9 (5): 543-54
80. Beydoun A, Shaibani A, Hopwood M, et al. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006; 113 (6): 395-404
81. Grosskopf J, Mazzola J, Wan Y, et al. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2006; 114 (3): 177-80
82. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy; a randomized, controlled study. Neurology 2001; 57 (3): 505-9
83. Vinik AI, Tuchman M, Safirstein B, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007; 128 (1-2): 169-79
84. Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004; 63 (5): 865-73
85. Thienel U, Neto W, Schwabe SK, et al. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004; 110 (4): 221-31
86. Atli A, Dogra S. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. Pain Med 2005; 6 (3): 225-34
87. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280 (21): 1831-6
88. Gorson KC, Schott C, Herman R, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double-blind, crossover trial. J Neurol Neurosurg Psychiatry 1999; 66 (2): 251-2
89. Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004; 63 (11): 2104-10
90. Rosenstock J, Michael TB, LaMoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110 (3): 628-38
91. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005; 6 (4): 253-60
92. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159 (16): 1931-7
93. Jose VM, Bhansali A, Hota D, et al. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007; 24 (4): 377-83
94. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 2001; 3 (2): 53-62
95. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pre-gabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005; 115: 254-63
96. Ambrosio AF, Soares-da-Silva P, Carvalho CM, et al. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024*. Neurochem Res 2002; 1-2: 121-30
97. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006; 61 (3): 246-55
98. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003; 2 (8): 473-81
99. Yaari Y, Devor M. Phenytoin suppresses spontaneous ectopic discharge in rat sciatic nerve neuromas. Neurosci Lett 1985; 58 (1): 117-22
100. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 2005; 5 (1): 3-14
101. Dam M, Ekberg R, Loyning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989; 3 (1): 70-6
102. Lees G, Leach MJ. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res 1993; 612 (1-2): 190-9
103. Anderson GD, Miller JW. The newer antiepileptic drugs: their collective role and defining characteristics. Formulary 2001; 36 (2): 114-25
104. Eisenberg E, River Y, Shifrin A, et al. Antiepileptic drugs in the treatment of neuropathic pain. Drugs 2007; 67 (9): 1265-89
105. Guerrini R, Parmeggiani L. Topiramate and its clinical applications in epilepsy. Exp Opin Pharmacother 2006; 7 (6): 811-23
106. Schauf CL. Zonisamide enhances slow sodium inactivation in myxicola. Brain Res 1987; 413 (1): 185-8
107. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002; 59 (5): S14-7
108. Stefani A, Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 1998; 37 (1): 83-91
109. Belliotti TR, Capiris T, Ekhato IV, et al. Structure-activity corelationships of pregabalin and analogues that target the alpha(2)-delta protein. J Med Chem 2005; 48 (7): 2294-307
110. Gee NS, Brown JP, Dissanayake VUK, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha(2)delta subunit of a calcium channel. J Biol Chem 1996; 271 (10): 5768-76
111. Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42 (2): 229-36
112. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003; 105 (1-2): 133-41
113. Cunningham MO, Woodhall GL, Thompson SE, et al. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 2004; 20 (6): 1566-76
114. Dooley DJ, Donovan CM, Meder WP, et al. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked H-3-nore-pinephrine release from rat neocortical slices. Synapse 2002; 45 (3): 171-90
115. Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent modulation of H-3 norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000; 295 (3): 1086-93
116. Maneuf YP, Hughes J, McKnight AT. Gabapentin inhibits the substance P-facilitated K+-evoked release of H-3 glutamate from rat caudal trigeminal nucleus slices. Pain 2001; 93 (2): 191-6
117. Guyatt GH, Townsend M, Berman LB, et al. A comparison of Likert and visual analogue scales for measuring change in function. J Chron Dis 1987; 40: 1129-33
118. Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005; (3): CD001133
119. Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 2004; 61 (1-3): 1-48
120. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33 (1): 11-23
121. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50 (6): 1842-6
122. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-8
123. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50 (6): 1837-41
124. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003; 104 (1-2): 323-31
125. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia; a randomized, placebo-controlled trial. Neurology 2002; 59 (7): 1015-21
126. Watson CPN, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71-8
127. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003; 60 (6): 927-34
128. Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 1997; 73 (2): 151-7
129. Kalso E. Oxycodone. J Pain Symptom Manage 2005; 29 (5): S47-56
130. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974; 7: 151-69
131. MacPherson RD. The pharmacological basis of contemporary pain management. Pharmacol Ther 2000; 88 (2): 163-85
132. Hollingshead J, Dühmke R, Cornblath D. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2005; (3): CD003726
133. Przewlocki R, Przewlocka B. Opioids in neuropathic pain. Curr Pharm Des; 11 (23): 3013-25
134. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005; 293 (24): 3043-51
135. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-80
136. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37 (2): 246-53
137. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65 (1): 39-44
138. Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80: 533-8
139. Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: result of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 2002; 18: 297-301
140. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989; 21 (2): 265-70
141. Watson CPN, Tyler KL, Bickers DR, et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15 (3): 510-26
142. Chad DA, Aronin N, Lundstrom R, et al. Does capsaicin relieve the pain of diabetic neuropathy. Pain 1990; 42 (3): 387-8
143. Donofrio P, Walker F, Hunt V, et al. Treatment of painful diabetic neuropathy with topical capsaicin; a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151 (11): 2225-9
144. Scheffler NM, Sheitel PL, Lipton MN. Treatment of painful diabetic neuropathy with capsaicin 0.075-percent. J Am Podiatr Med Assoc 1991; 81 (6): 288-93
145. Tandan R, Lewis GA, Krusinski PB, et al. Topical capsaicin in painful diabetic neuropathy. Diabetes Care 1992; 15 (1): 8-14
146. Low PA, Opfergehrking TL, Dyck PJ, et al. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995; 62 (2): 163-8
147. Biesbroeck R, Bril V, Hollander P, et al. A double-blind comparison of topical and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995; 12 (2): 111-20
148. Argoff CE. New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000; 16 (2): S62-6
149. Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev 2007; (2): CD004846
150. Lynn B. Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain 1990; 41 (1): 61-9
151. Fitzgerald M. Capsaicin and sensory neurones: a review. Pain 1983; 15 (1-4): 109-30
152. Rains C, Bryson HM. Topical capsaicin; a review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 1995; 7 (4): 317-28
153. Watson CPN. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994; 9 (7): 425-33
154. Criner TM, Perdun CS. Dextromethorphan and diabetic neuropathy. Ann Pharmacother 1999; 33 (11): 1221-3
155. Sang CN, Booher S, Gilron I, et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia; efficacy and dose-response trials. Anesthesiology 2002; 96 (5): 1053-61
156. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48 (5): 1212-8
157. Eisenberg E, Kleiser A, Dortort A, et al. The NMDA (N-methyl-D- aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur J Pain 1998; 2 (4): 321-7
158. Chizh BH, Headley PM. NMDA antagonists and neuropathic pain: multiple drug and targets and multiple uses. 2005; 11: 2977-94
159. Raja SN, Haythornthwaite JA. Combination therapy for neuropathic pain: which drugs, which combination, which patients? N Engl J Med 2005; 352 (13): 1373-5
160. Gilron I, Bailey JM, Tu DS, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352 (13): 1324-34
161. Rauck RL, Shaibani A, Biton V, et al. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain 2007; 23 (2): 150-8
162. Pappagallo M, Haldey EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs 2003; 17 (11): 771-80
163. Harden N, Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manage 2003; 25 (5 Suppl.): S12-7
164. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353 (9168): 1959-64
165. Baron R. Mechanisms of disease: neuropathic pain: a clinical perspective. Nat Clin Prac Neurol 2006; 2 (2): 95-106
166. Smith HS, Sang CN. The evolving nature of neuropathic pain: individualizing treatment. Eur J Pain 2002; 6: 13-8
167. Ross FB, Wallis SC, Smith MT. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 2000; 84 (2-3): 421-8
168. Caraceni A, Zecca E, Martini C, et al. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 1999; 17 (6): 441-5
169. Eckhardt K, Ammon S, Hofmann U, et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000; 91 (1): 185-91
170. Shimoyama M, Shimoyama N, Inturrisi CE, et al. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 1997; 72 (3): 375-82
171. Virani A, Mailis A, Shapiro LE, et al. Drug interactions in human neuropathic pain pharmacotherapy. Pain 1997; 73 (1): 3-13